Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Radiotherapy
100%
F-18
100%
Hypoxia
100%
PET Imaging
100%
Therapeutic Outcome
100%
TH-302
100%
Hypoxic Fraction
40%
Tumor
30%
Rhabdomyosarcoma
30%
Tumor Oxygenation
20%
Combination Treatment
20%
H460
20%
Oxygenation Status
20%
Treatment Efficacy
10%
Oxygen Effect
10%
Therapeutic Effect
10%
Patient Selection
10%
Tumor Treatment
10%
Targeting Mechanism
10%
Tumor Model
10%
Tumor Growth
10%
Non-small Cell Lung Cancer (NSCLC)
10%
Hypoxic Tumors
10%
Mechanism of Action
10%
Tumor Region
10%
Anticancer Treatment
10%
Treatment Toxicity
10%
Nicotinamide
10%
Carbogen
10%
Clinical Testing
10%
Pimonidazole
10%
Enhancement Ratio
10%
Radiation Enhancement
10%
Hypoxia Targeting
10%
Cytotoxic Agents
10%
Tumor-bearing Animals
10%
Growth Delay
10%
In Vitro Tumor Models
10%
Oxygen Modification
10%
IHC Staining
10%
Companion Biomarker
10%
Medicine and Dentistry
Positron Emission Tomography
100%
Neoplasm
100%
Hypoxia
100%
Radiation Therapy
100%
Rhabdomyosarcoma
42%
Tumor Model
28%
Biological Marker
14%
Combination Therapy
14%
Patient Selection
14%
Single Drug Dose
14%
Therapy Effect
14%
Tumor Progression
14%
Cancer Treatment
14%
Carbogen
14%
Non-Small Cell Lung Cancer
14%
Pimonidazole
14%
Oxygen Breathing
14%
Nicotinamide
14%
Cytotoxic Agent
14%
INIS
tumors
100%
hypoxia
100%
radiotherapy
100%
positron computed tomography
100%
oxygen
40%
rhabdomyosarcomas
30%
animals
20%
growth
20%
testing
10%
doses
10%
patients
10%
volume
10%
increasing
10%
design
10%
biological markers
10%
toxicity
10%
modifications
10%
breathing
10%
nicotinamide
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Hypoxia
100%
Polyethylene Terephthalate
100%
Rhabdomyosarcoma
42%
Tumor Model
28%
Tumor Growth
14%
Biological Marker
14%
Combination Therapy
14%
Therapeutic Effect
14%
Carbogen
14%
Nicotinamide
14%
Pimonidazole
14%
Cytotoxic Agent
14%
Immunology and Microbiology
Positron Emission Tomography
100%
Oxygenation
50%
Oxygen Breathing
25%